1
|
Kehr NS. The Effect of Co-Delivery of Oxygen and Anticancer Drugs on the Viability of Healthy and Cancer Cells under Normoxic and Hypoxic Conditions. Macromol Biosci 2024:e2400181. [PMID: 38980997 DOI: 10.1002/mabi.202400181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Revised: 06/04/2024] [Indexed: 07/11/2024]
Abstract
Hypoxia, cancer, tissue damage, and acidic pH conditions are interrelated, as chronic hypoxic conditions enhance the malignant phenotype of cancer cells, causing more aggressive tissue destruction, and hypoxic cells rely on anaerobic glycolysis, leading to the accumulation of lactic acid. Therefore, the administration of oxygen is necessary to support the functions of healthy cells until the formation of new blood vessels and to increase the oxygen supply to cancerous tissues to improve the efficacy of antitumor drugs on tumor cells. In addition to O2 supply, pH-dependent delivery of anticancer drugs is desired to target cancer cells and reduce drug side effects on healthy cells. However, the simultaneous delivery of O2 and pH-dependent anticancer drugs via nanomaterials and their effects on the viability of normal and cancer cells under hypoxic conditions have not been studied in sufficient numbers. This study describes the synthesis of a pH-responsive nanomaterial containing oxygen and anticancer drugs that exhibits sustained O2 release over a 14 d period under hypoxic conditions and pH-dependent sustained release of anticancer drugs over 30 d. The simultaneous administration of O2 and anticancer drugs results in higher cell survival of normal cells than that of cancer cells under hypoxic and normoxic conditions.
Collapse
Affiliation(s)
- Nermin Seda Kehr
- Department of Chemistry, Izmir Institute of Technology, Urla/Izmir, 35430, Turkiye
| |
Collapse
|
2
|
Zhao J, Zhou C, Xiao Y, Zhang K, Zhang Q, Xia L, Jiang B, Jiang C, Ming W, Zhang H, Long H, Liang W. Oxygen generating biomaterials at the forefront of regenerative medicine: advances in bone regeneration. Front Bioeng Biotechnol 2024; 12:1292171. [PMID: 38282892 PMCID: PMC10811251 DOI: 10.3389/fbioe.2024.1292171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Accepted: 01/02/2024] [Indexed: 01/30/2024] Open
Abstract
Globally, an annual count of more than two million bone transplants is conducted, with conventional treatments, including metallic implants and bone grafts, exhibiting certain limitations. In recent years, there have been significant advancements in the field of bone regeneration. Oxygen tension regulates cellular behavior, which in turn affects tissue regeneration through metabolic programming. Biomaterials with oxygen release capabilities enhance therapeutic effectiveness and reduce tissue damage from hypoxia. However, precise control over oxygen release is a significant technical challenge, despite its potential to support cellular viability and differentiation. The matrices often used to repair large-size bone defects do not supply enough oxygen to the stem cells being used in the regeneration process. Hypoxia-induced necrosis primarily occurs in the central regions of large matrices due to inadequate provision of oxygen and nutrients by the surrounding vasculature of the host tissues. Oxygen generating biomaterials (OGBs) are becoming increasingly significant in enhancing our capacity to facilitate the bone regeneration, thereby addressing the challenges posed by hypoxia or inadequate vascularization. Herein, we discussed the key role of oxygen in bone regeneration, various oxygen source materials and their mechanism of oxygen release, the fabrication techniques employed for oxygen-releasing matrices, and novel emerging approaches for oxygen delivery that hold promise for their potential application in the field of bone regeneration.
Collapse
Affiliation(s)
- Jiayi Zhao
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Chao Zhou
- Department of Orthopedics, Zhoushan Guanghua Hospital, Zhoushan, China
| | - Yang Xiao
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Kunyan Zhang
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Qiang Zhang
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Linying Xia
- Medical Research Center, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Bo Jiang
- Rehabilitation Department, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Chanyi Jiang
- Department of Pharmacy, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Wenyi Ming
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Hengjian Zhang
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Hengguo Long
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| | - Wenqing Liang
- Department of Orthopaedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan, China
| |
Collapse
|
3
|
Khorshidi S, Karkhaneh A. Cylindrical polyester/calcium peroxide oxygen-releasing microparticles: molecular dynamics simulation and experimental analyses. IRANIAN POLYMER JOURNAL 2023. [DOI: 10.1007/s13726-022-01098-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
4
|
Aleemardani M, Solouk A, Akbari S, Moeini M. A hydrogel-fiber-hydrogel composite scaffold based on silk fibroin with the dual-delivery of oxygen and quercetin. Biotechnol Bioeng 2023; 120:297-311. [PMID: 36224726 DOI: 10.1002/bit.28259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 09/04/2022] [Accepted: 10/08/2022] [Indexed: 11/10/2022]
Abstract
Supplying sufficient oxygen within the scaffolds is one of the essential hindrances in tissue engineering that can be resolved by oxygen-generating biomaterials (OGBs). Two main issues related to OGBs are controlling oxygenation and reactive oxygen species (ROS). To address these concerns, we developed a composite scaffold entailing three layers (hydrogel-electrospun fibers-hydrogel) with antioxidant and antibacterial properties. The fibers, the middle layer, reinforced the composite structure, enhancing the mechanical strength from 4.27 ± 0.15 to 8.27 ± 0.25 kPa; also, this layer is made of calcium peroxide and silk fibroin (SF) through electrospinning, which enables oxygen delivery. The first and third layers are physical SF hydrogels to control oxygen release, containing quercetin (Q), a nonenzymatic antioxidant. This composite scaffold resulted in almost more than 40 mmHg of oxygen release for at least 13 days, and compared with similar studies is in a high range. Here, Q was used for the first time for an OGB to scavenge the possible ROS. Q delivery not only led to antioxidant activity but also stabilized oxygen release and enhanced cell viability. Based on the given results, this composite scaffold can be introduced as a safe and controllable oxygen supplier, which is promising for tissue engineering applications, particularly for bone.
Collapse
Affiliation(s)
- Mina Aleemardani
- Biomaterials and Tissue Engineering Group, Department of Materials Science and Engineering, Kroto Research Institute, The University of Sheffield, Sheffield, UK
| | - Atefeh Solouk
- Biomedical Engineering Department, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran
| | - Somaye Akbari
- Department of Textile Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran
| | - Mohammad Moeini
- Biomedical Engineering Department, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran
| |
Collapse
|
5
|
Motealleh A, Schäfer AH, Fromm O, Kehr NS. 3D-Printed Oxygen-Carrying Nanocomposite Hydrogels for Enhanced Cell Viability under Hypoxic and Normoxic Conditions. Biomacromolecules 2021; 22:4758-4769. [PMID: 34605650 DOI: 10.1021/acs.biomac.1c01067] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Insufficient and heterogeneous oxygen (O2) distribution within engineered tissues results in hypoxic conditions. Hypoxia is one of the characteristics of solid tumors. To date, very few studies have used an O2-deliverable injectable hydrogel for cancer treatment under hypoxic conditions. In this field, we describe a new O2-carrying nanomaterial and an injectable nanocomposite hydrogel (PMOF and AlgL-PMOF, respectively) that can provide extended oxygen levels for cell survival under hypoxia. Particularly, PMOF and AlgL-PMOF enhance cell viability under hypoxic and normoxic cell culturing conditions. Moreover, sustained oxygen availability in the presence of an anticancer drug within the 3D network of AlgL-PMOF results in a decrease in the viability of malignant and immortal cells, while the viability of healthy cells increases.
Collapse
Affiliation(s)
- Andisheh Motealleh
- Physikalisches Institute and Center for Soft Nanoscience, Westfälische Wilhelms-Universität Münster, Busse-Peus-Strasse 10, 48149 Münster, Germany
| | | | - Olga Fromm
- MEET─Münster Electrochemical Energy Technology, Correnstrasse 46, 48149 Münster, Germany
| | - Nermin S Kehr
- Physikalisches Institute and Center for Soft Nanoscience, Westfälische Wilhelms-Universität Münster, Busse-Peus-Strasse 10, 48149 Münster, Germany
| |
Collapse
|
6
|
Dadashzadeh A, Moghassemi S, Shavandi A, Amorim CA. A review on biomaterials for ovarian tissue engineering. Acta Biomater 2021; 135:48-63. [PMID: 34454083 DOI: 10.1016/j.actbio.2021.08.026] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Revised: 07/26/2021] [Accepted: 08/18/2021] [Indexed: 12/19/2022]
Abstract
Considerable challenges in engineering the female reproductive tissue are the follicle's unique architecture, the need to recapitulate the extracellular matrix, and tissue vascularization. Over the years, various strategies have been developed for preserving fertility in women diagnosed with cancer, such as embryo, oocyte, or ovarian tissue cryopreservation. While autotransplantation of cryopreserved ovarian tissue is a viable choice to restore fertility in prepubertal girls and women who need to begin chemo- or radiotherapy soon after the cancer diagnosis, it is not suitable for all patients due to the risk of having malignant cells present in the ovarian fragments in some types of cancer. Advances in tissue engineering such as 3D printing and ovary-on-a-chip technologies have the potential to be a translational strategy for precisely recapitulating normal tissue in terms of physical structure, vascularization, and molecular and cellular spatial distribution. This review first introduces the ovarian tissue structure, describes suitable properties of biomaterials for ovarian tissue engineering, and highlights recent advances in tissue engineering for developing an artificial ovary. STATEMENT OF SIGNIFICANCE: The increase of survival rates in young cancer patients has been accompanied by a rise in infertility/sterility in cancer survivors caused by the gonadotoxic effect of some chemotherapy regimens or radiotherapy. Such side-effect has a negative impact on these patients' quality of life as one of their main concerns is generating biologically related children. To aid female cancer patients, several research groups have been resorting to tissue engineering strategies to develop an artificial ovary. In this review, we discuss the numerous biomaterials cited in the literature that have been tested to encapsulate and in vitro culture or transplant isolated preantral follicles from human and different animal models. We also summarize the recent advances in tissue engineering that can potentially be optimal strategies for developing an artificial ovary.
Collapse
|
7
|
Erdem A, Haghniaz R, Ertas YN, Sangabathuni SK, Nasr AS, Swieszkowski W, Ashammakhi N. Methods for fabricating oxygen releasing biomaterials. J Drug Target 2021; 30:188-199. [PMID: 34486908 DOI: 10.1080/1061186x.2021.1971235] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Sustained external supply of oxygen (O2) to engineered tissue constructs is important for their survival in the body while angiogenesis is taking place. In the recent years, the trend towards the fabrication of various O2-generating materials that can provide prolonged and controlled O2 source to the large volume tissue constructs resulted in preventing necrosis associated with the lack of O2 supply. In this review, we explain different methods employed in the fabrication of O2-generating materials such as emulsion, microfluidics, solvent casting, freeze drying, electrospraying, gelation, microfluidic and three-dimensional (3D) bioprinting methods. After discussing pros and cons of each method, we review physical, chemical, and biological characterisation techniques used to analyse the resulting product. Finally, the challenges and future directions in the field are discussed.
Collapse
Affiliation(s)
- Ahmet Erdem
- Department of Biomedical Engineering, Kocaeli University, Kocaeli, Turkey
| | - Reihaneh Haghniaz
- Department of Bioengineering, University of California - Los Angeles, Los Angeles, California, USA
| | - Yavuz Nuri Ertas
- Department of Biomedical Engineering, Erciyes University, Kayseri, Turkey.,ERNAM - Nanotechnology Research and Application Center, Erciyes University, Kayseri, Turkey
| | - Siva Koti Sangabathuni
- Department of Bioengineering, University of California - Los Angeles, Los Angeles, California, USA
| | - Ali S Nasr
- Division of Cardiothoracic Surgery, Department of Surgery, University of Iowa Hospitals and Clinics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
| | - Wojciech Swieszkowski
- Biomaterials Group, Materials Design Division, Faculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland
| | - Nureddin Ashammakhi
- Department of Bioengineering, University of California - Los Angeles, Los Angeles, California, USA
| |
Collapse
|
8
|
Alghamdi M, Gumbleton M, Newland B. Local delivery to malignant brain tumors: potential biomaterial-based therapeutic/adjuvant strategies. Biomater Sci 2021; 9:6037-6051. [PMID: 34357362 DOI: 10.1039/d1bm00896j] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Glioblastoma (GBM) is the most aggressive malignant brain tumor and is associated with a very poor prognosis. The standard treatment for newly diagnosed patients involves total tumor surgical resection (if possible), plus irradiation and adjuvant chemotherapy. Despite treatment, the prognosis is still poor, and the tumor often recurs within two centimeters of the original tumor. A promising approach to improving the efficacy of GBM therapeutics is to utilize biomaterials to deliver them locally at the tumor site. Local delivery to GBM offers several advantages over systemic administration, such as bypassing the blood-brain barrier and increasing the bioavailability of the therapeutic at the tumor site without causing systemic toxicity. Local delivery may also combat tumor recurrence by maintaining sufficient drug concentrations at and surrounding the original tumor area. Herein, we critically appraised the literature on local delivery systems based within the following categories: polymer-based implantable devices, polymeric injectable systems, and hydrogel drug delivery systems. We also discussed the negative effect of hypoxia on treatment strategies and how one might utilize local implantation of oxygen-generating biomaterials as an adjuvant to enhance current therapeutic strategies.
Collapse
Affiliation(s)
- Majed Alghamdi
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK. and Faculty of Pharmacy, King Abdulaziz University, Jeddah, 22522, Kingdom of Saudi Arabia
| | - Mark Gumbleton
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK.
| | - Ben Newland
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK. and Leibniz-Institut für Polymerforschung Dresden, Max Bergmann Center of Biomaterials Dresden, Hohe Straße 6, D-01069 Dresden, Germany
| |
Collapse
|
9
|
Guo Z, Poot AA, Grijpma DW. Advanced polymer-based composites and structures for biomedical applications. Eur Polym J 2021. [DOI: 10.1016/j.eurpolymj.2021.110388] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
10
|
Motealleh A, Kehr NS. Injectable oxygen-generating nanocomposite hydrogels with prolonged oxygen delivery for enhanced cell proliferation under hypoxic and normoxic conditions. J Mater Chem B 2021; 8:4195-4201. [PMID: 32393933 DOI: 10.1039/d0tb00885k] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
We describe a new organic peroxide-based injectable biomaterial that was prepared by using benzoylperoxide and LAPONITE® incorporated into an alginate hydrogel (BPO-AlgL). BPO-AlgL shows sustained release of O2 over a period of 14 days and reduces the hypoxia-induced cell death. BPO-AlgL also promotes enhanced cell viability by providing sustained O2 within the 3D AlgL scaffold. In addition, BPO-AlgL increases the O2 level in the environment of the cells, which led to a decrease in the proliferation of malignant cells, while it also resulted in an increase in the viability of healthy fibroblast cells. Therefore, our new oxygen generating organic peroxide-based injectable 3D biomaterials have potential to contribute in the development of next generation advanced tissue engineering biomaterials.
Collapse
Affiliation(s)
- Andisheh Motealleh
- Physikalisches Institute and Center for Soft Nanoscience, Westfälische Wilhelms-Universität Münster, Busse-Peus-Strasse 10, Münster 48149, Germany.
| | - Nermin S Kehr
- Physikalisches Institute and Center for Soft Nanoscience, Westfälische Wilhelms-Universität Münster, Busse-Peus-Strasse 10, Münster 48149, Germany.
| |
Collapse
|
11
|
Willemen NGA, Hassan S, Gurian M, Li J, Allijn IE, Shin SR, Leijten J. Oxygen-Releasing Biomaterials: Current Challenges and Future Applications. Trends Biotechnol 2021; 39:1144-1159. [PMID: 33602609 DOI: 10.1016/j.tibtech.2021.01.007] [Citation(s) in RCA: 39] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2020] [Revised: 01/18/2021] [Accepted: 01/19/2021] [Indexed: 12/22/2022]
Abstract
Oxygen is essential for the survival, function, and fate of mammalian cells. Oxygen tension controls cellular behaviour via metabolic programming, which in turn controls tissue regeneration, stem cell differentiation, drug metabolism, and numerous pathologies. Thus, oxygen-releasing biomaterials represent a novel and unique strategy to gain control over a variety of in vivo processes. Consequently, numerous oxygen-generating or carrying materials have been developed in recent years, which offer innovative solutions in the field of drug efficiency, regenerative medicine, and engineered living systems. In this review, we discuss the latest trends, highlight current challenges and solutions, and provide a future perspective on the field of oxygen-releasing materials.
Collapse
Affiliation(s)
- Niels G A Willemen
- Department of Developmental BioEngineering, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands; Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, MA 02139, USA
| | - Shabir Hassan
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, MA 02139, USA
| | - Melvin Gurian
- Department of Developmental BioEngineering, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands
| | - Jinghang Li
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, MA 02139, USA; School of Materials Science and Engineering, Wuhan Institute of Technology, Wuhan, 430205, China
| | - Iris E Allijn
- Department of Developmental BioEngineering, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands
| | - Su Ryon Shin
- Division of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, MA 02139, USA.
| | - Jeroen Leijten
- Department of Developmental BioEngineering, Faculty of Science and Technology, Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.
| |
Collapse
|
12
|
Daneshmandi L, Laurencin CT. Regenerative engineered vascularized bone mediated by calcium peroxide. J Biomed Mater Res A 2020; 108:1045-1057. [PMID: 31925886 DOI: 10.1002/jbm.a.36879] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 12/29/2019] [Accepted: 12/31/2019] [Indexed: 12/20/2022]
Abstract
One of the main challenges hindering the clinical translation of bone tissue engineering scaffolds is the lack of establishment of functional vasculature. Insufficient vascularization and poor oxygen supply limit cell survival within the constructs resulting in poor osseointegration with the host tissue and eventually leading to inadequate bone regeneration. Inspired by cues from developmental biology, we regenerative engineered a composite matrix by incorporating calcium peroxide (CaO2 ) into poly(lactide-co-glycolide) (PLGA) microsphere-based matrices and sought to assess whether the delivery of the byproducts of CaO2 decomposition, namely O2 , Ca2+ , and H2 O2 could enhance the regeneration of vascularized bone tissue. The composite microspheres were successfully fabricated via the oil-in-water emulsion method. The presence and encapsulation of CaO2 was confirmed using scanning electron microscopy, energy dispersive x-ray spectroscopy, thermogravimetric analysis, and X-ray powder diffraction. The microspheres were further heat sintered into three-dimensional porous scaffolds and characterized for their degradation and release of byproducts. The in vitro cytocompatibility of the matrices and their ability to support osteogenic differentiation was confirmed using human adipose-derived stem cells. Lastly, an in vivo study was performed in a mouse critical-sized calvarial defect model to evaluate the capacity of these matrices in supporting vascularized bone regeneration. Results demonstrated that the presence of CaO2 increased cellularization and biological activity throughout the matrices. There was greater migration of host cells to the interior of the matrices and greater survival and persistence of donor cells after 8 weeks, which in synergy with the composite matrices led to enhanced vascularized bone regeneration.
Collapse
Affiliation(s)
- Leila Daneshmandi
- Connecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, Farmington, Connecticut.,Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, UConn Health, Farmington, Connecticut.,Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut.,Department of Orthopaedic Surgery, UConn Health, Farmington, Connecticut
| | - Cato T Laurencin
- Connecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, Farmington, Connecticut.,Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, UConn Health, Farmington, Connecticut.,Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut.,Department of Orthopaedic Surgery, UConn Health, Farmington, Connecticut.,Institute of Materials Science, University of Connecticut, Storrs, Connecticut.,Department of Materials Science and Engineering, University of Connecticut, Storrs, Connecticut.,Department of Chemical and Biomolecular Engineering, University of Connecticut, Storrs, Connecticut
| |
Collapse
|
13
|
Zhang M, Kiratiwongwan T, Shen W. Oxygen‐releasing polycaprolactone/calcium peroxide composite microspheres. J Biomed Mater Res B Appl Biomater 2019; 108:1097-1106. [DOI: 10.1002/jbm.b.34461] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Revised: 07/03/2019] [Accepted: 07/24/2019] [Indexed: 11/06/2022]
Affiliation(s)
- Mengen Zhang
- Department of Biomedical Engineering University of Minnesota Minneapolis Minnesota
| | - Tawan Kiratiwongwan
- Department of Biomedical Engineering University of Minnesota Minneapolis Minnesota
| | - Wei Shen
- Department of Biomedical Engineering University of Minnesota Minneapolis Minnesota
| |
Collapse
|
14
|
Ashammakhi N, Darabi MA, Kehr NS, Erdem A, Hu SK, Dokmeci MR, Nasr AS, Khademhosseini A. Advances in Controlled Oxygen Generating Biomaterials for Tissue Engineering and Regenerative Therapy. Biomacromolecules 2019; 21:56-72. [DOI: 10.1021/acs.biomac.9b00546] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Nureddin Ashammakhi
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Radiological Sciences, David Geffen School of Medicine, University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
| | - Mohammad Ali Darabi
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Radiological Sciences, David Geffen School of Medicine, University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
| | - Nermin Seda Kehr
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
- Physikalisches Institut
and Center for Soft Nanoscience, Westfälische Wilhelms-Universität Münster, Busse-Peus-Strasse 10, 48149 Münster, Germany
| | - Ahmet Erdem
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Chemistry, Kocaeli University, Umuttepe Campus, 41380 Kocaeli, Turkey
- Department of Biomedical Engineering, Kocaeli University, Umuttepe Campus, 41380 Kocaeli, Turkey
| | - Shu-kai Hu
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
- Physikalisches Institut
and Center for Soft Nanoscience, Westfälische Wilhelms-Universität Münster, Busse-Peus-Strasse 10, 48149 Münster, Germany
| | - Mehmet R. Dokmeci
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Radiological Sciences, David Geffen School of Medicine, University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
| | - Ali S. Nasr
- Division of Cardiothoracic Surgery, Department of Surgery, University of Iowa Hospitals and Clinics, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, United States
| | - Ali Khademhosseini
- Center for Minimally
Invasive Therapeutics (C-MIT), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Radiological Sciences, David Geffen School of Medicine, University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Bioengineering, University of California−Los Angeles, Los Angeles, California 90095, United States
- California NanoSystems
Institute (CNSI), University of California−Los Angeles, Los Angeles, California 90095, United States
- Department of Chemical Engineering, University of California−Los Angeles, Los Angeles, California 90095, United States
| |
Collapse
|
15
|
Newland H, Eigel D, Rosser AE, Werner C, Newland B. Oxygen producing microscale spheres affect cell survival in conditions of oxygen-glucose deprivation in a cell specific manner: implications for cell transplantation. Biomater Sci 2018; 6:2571-2577. [PMID: 30132477 PMCID: PMC6157640 DOI: 10.1039/c8bm00490k] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Accepted: 06/27/2018] [Indexed: 12/31/2022]
Abstract
This study outlines the synthesis of microscale oxygen producing spheres, which, when used in conjunction with catalase, can raise the dissolved oxygen content of cell culture media for 16-20 hours. In conditions of oxygen and glucose deprivation, designed to mimic the graft environment in vivo, the spheres rescue SH-SY5Y cells and meschymal stem cells, showing that oxygen producing biomaterials may hold potential to improve the survival of cells post-transplantation.
Collapse
Affiliation(s)
- Heike Newland
- Leibniz Institute of Polymer Research Dresden (IPF)
,
Hohe Strasse 6
, 01069 Dresden
, Germany
| | - Dimitri Eigel
- Leibniz Institute of Polymer Research Dresden (IPF)
,
Hohe Strasse 6
, 01069 Dresden
, Germany
| | - Anne E. Rosser
- Brain Repair Group
, School of Biosciences
, Cardiff University
,
CF10 3AX
, UK
| | - Carsten Werner
- Leibniz Institute of Polymer Research Dresden (IPF)
,
Hohe Strasse 6
, 01069 Dresden
, Germany
| | - Ben Newland
- Leibniz Institute of Polymer Research Dresden (IPF)
,
Hohe Strasse 6
, 01069 Dresden
, Germany
- School of Pharmacy and Pharmaceutical Sciences
, Cardiff University
,
CF10 3NB
, UK
.
| |
Collapse
|
16
|
Rastinfard A, Nazarpak MH, Moztarzadeh F. Controlled chemical synthesis of CaO2 particles coated with polyethylene glycol: characterization of crystallite size and oxygen release kinetics. RSC Adv 2018. [DOI: 10.1039/c7ra08758f] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
The oxygen release pattern of CaO2 nanoparticles was biphasic: an initial burst phase for the first 24 hours followed by a descending release rate for three days. The oxygen release rate in the second phase mainly depended on the shrinking-core model for CaO2 hydrolysis.
Collapse
Affiliation(s)
- Arghavan Rastinfard
- Department of Biomedical Engineering
- Amirkabir University of Technology
- Tehran 159163-4311
- Iran
| | | | - Fathollah Moztarzadeh
- Department of Biomedical Engineering
- Amirkabir University of Technology
- Tehran 159163-4311
- Iran
| |
Collapse
|